tldrdailynews.com logo

Trump's Drug Pricing Initiative Gains Momentum with Pfizer Deal and TrumpRx Launch

1 min read
Source: CNBC
Trump's Drug Pricing Initiative Gains Momentum with Pfizer Deal and TrumpRx Launch
Photo: CNBC
TL;DR

President Trump’s threat of pharmaceutical tariffs has been softened after Pfizer’s deal to lower U.S. drug prices and invest $70 billion in domestic manufacturing, leading to a temporary exemption from tariffs and easing industry concerns about punitive measures and the most-favored-nation policy.

Topics:nationbusiness#business#drug-pricing#pfizer#pharmaceutical-tariffs#trump-administration#us-manufacturing
Share this article
  1. Trump's pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers  CNBC
  2. How Trump’s Drug-Buying Site ‘TrumpRx’ Will Work  The Wall Street Journal
  3. President announces TrumpRx website for drugs, and pricing deal with Pfizer  NPR
  4. Trump Announces Pfizer Deal to Lower Some Drug Prices and Unveils TrumpRx Website  The New York Times
  5. Fact Sheet: President Donald J. Trump Announces First Deal to Bring Most-Favored-Nation Pricing to American Patients  The White House (.gov)

Want the full story? Read the original reporting

Read on CNBC